Biocompatibility of mannuronic acid-rich alginates

Biomaterials

Volumn 18, Issue 10, 1997, Pages 707-713

  Klöck, Gerd ^a   Pfeffermann, Anja ^a   Ryser, Christoph ^a   Gröhn, Patrik ^a   Kuttler, Beate ^b   Hahn, Hans Jürgen ^b   Zimmermann, Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Alginate; Bioartificial organs; Biocompatibility; Implantable hydrogels; Tissue engineering

Indexed keywords

ARTIFICIAL ORGANS; BIOASSAY; BIOCOMPATIBILITY; CROSSLINKING; HYDROGELS; IONS; MECHANICAL PERMEABILITY; PURIFICATION; SOLVENTS;

ALGINATES; ENDOTOXINS; LYMPHOCYTES; MANNURONIC ACID; MITOGENIC ACTIVITY;

BIOMATERIALS;

ALGINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CELL TRANSPLANTATION; DIFFUSION; ENCAPSULATION; IMMOBILIZED CELL; IMMUNE SYSTEM; LYMPHOCYTE; MACROPHAGE; MALE; MICROCAPSULE; MITOGENESIS; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PURIFICATION; RAT; VISCOSITY;

ANIMALIA; MURINAE;

EID: 0343247782     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(96)00204-9     Document Type: Article

References (37)

1. Smithrod, O. and Skjaek-Braek, G., Alginate as an immobilization matrix for cells. Trends Biotechnol., 1990, 8, 71-78.
2. Schnabl, H. and Zimmermann, U., Immobilization of plant protoplasts. In Plant Protoplasts and Genetic Engineering, Vol. 1, ed. Y. P. S. Bajay. Springer, Berlin, 1989, pp. 63-96.
3. Brodelius, P. and Vandamme, E. J., Immobilized cell systems. In Biotechnology, Vol. 7a, eds H. J. Rehm and G. Reed. Verlag Chemie, Weinheim, 1987, pp. 405-464.
4. Skjaek-Braek, G. and Martinsen, A., Application of some algal polysaccharides in biotechnology. In Seaweed Resources in Europe: Uses and Potential, ed. M. D. Guiry and G. Blunden. John Wiley, New York, 1991, pp. 219-257
5. Clayton, H. A., James, R. F. L. and London, N. J. M., Islet microencapsulation: a review. Acta Diabetol., 1993, 30, 181-189.
6. Colton, C. K., Implantable bioartificial organs. Cell Transplantation, 1995, 4, 415-436.
7. 2+, Biotechnol. Tech., 1988, 2, 115-120.
8. Geisen, K., Deutschländer, H., Gorbach, S., Klenke, C. and Zimmermann, U., Function of barium-alginate microencapsulated xenogenic islets in different diabetic mouse models. In Frontiers in Diabetes Research, ed. E. Shafrir. Lessons from animal diabetes III, Vol. 8, 1990, pp. 142-148.
9. Zekorn, T., Horcher, A., Siebers, U. et al., Barium-cross-linked alginate beads: a simple one-step method for successful immuno-isolated transplantation of islets of Langerhans. Acta Diabetol., 1992, 29, 99-106.
10. Zekorn, T., Siebers, U., Horcher, A., Zimmermann, U., Bretzel, R. G. and Federlin, K., Alginate coating of islets: a new technique for microencapsulation. Acta Diabetol., 1992, 29, 1-5.
11. Hasse, C., Stinner, B., Schrezenmeier, J. and Rothmund, M., Successful xenotransplantation of microencapsulated parathyroid tissue: evidence of long-term function without immunosuppression in an animal experiment. Langenbecks Arch. Chir.: Chir. Forum '94 Exp. Klin. Forsch., 1994, 209-212.
12. Gröhn, P, Klöck, G., Zimmermann, U. et al., Large scale production of barium alginate microcapsules for immunoisolation. Clin. Exp. Endocrinol., 1994, 102, 380-387.
13. Klein, J., Stock, J. and Vorlop, K. D., Pore size and properties of spherical Ca alginate biocatalysts. Eur. J. Microb. Biotechnol., 1983, 18, 86-91.
14. Stewart W. W. and Swaisgood, H. E., Characterization of calcium alginate pore diameter by size-exclusion chromatography using protein standards. Enzyme Microb. Technol., 1993, 15, 922-927.
15. Otterlei, M., Ostgaard, K., Skjaek-Braek, G., Smidsrod, O., Soon-Shiong, P. and Espevik, T., Induction of cytokine production from human monocytes stimualted with alginate. J. Immunother., 1991, 10, 286-291.
16. Soon-Shiong, P., Otterlei, M., Skjaek-Braek, G. et al., An immunologic basis for the fibrotic reaction to implanted microcapsules. Transplant Proc., 1991, 23, 758-759.
17. Espevik, T., Otterlei, M., Skjaek-Braek, G., Ryan, L., Wright, S. D. and Sundan, A., The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol., 1993, 23, 255-261.
18. Otterlei, M., Sundan, A., Skjak-Braek, G., Ryan, L., Smidsrod, O. and Espevik, T., Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect. Immun., 1993, 61, 1917-1925.
19. Pueyo, M. E., Darquy, S., Capron, F. and Reach, G., In vitro activation of human macrophages by alginate polylysine microcapsules. J. Biomater. Sci., 1993, 5, 197-203.
20. Zekorn, T., Klöck, G., Horcher, A. et al., Lymphoid activation by different crude alginates and the effect of purification. Transplant Proc., 1992, 24, 2952-2953.
21. Zimmermann, U., Klöck, G., Federlin, K. et al., Production of mitogen contaminant free alginates with variable ratios of mannuronic to guluronic acid by free-flow electrophoresis. Electrophoresis, 1992, 13, 269-274.
22. Klöck, G., Frank, H., Houben, R. et al., Production of purified alginates suitable for use in immunoisolated transplantation. Appl. Microbiol. Biotechnol., 1994, 40, 638-643.
23. Siebers, U., Horcher, A., Bretzel, R. G. et al., Histocompatibility of different alginates in rats. Horm. Metab. Res., 1993, 25, 67.
24. Kelco algin, Hydrophilic Derivatives of Alginic Acid for Scientific Water Control. Kelco Div. of Merck and Co., San Diego, p. 51.
25. Skjaek-Braek, G., Murano, E. and Poaletti, S., Alginate as immobilization material. II. Determination of polyphenolic contaminants by fluorescence spectroscopy and evaluation of methods for their removal. Biotechnol. Bioeng., 1989, 33, 90-94.
26. Hasszufaluzi, N., Chan, E., Granger, G. and Charles, M. A., Quantitative analysis comparing all major spleen cell phenotypes in BB and normal rats: autoimmune imbalance and double negative T cells associated with resistant, prone and diabetic animals. J. Autoimmun., 1992, 5, 305-318.
27. Rothe, H., Fehsel, K. and Kolb, H., Tumor necrosis factor alpha production is upregulated in diabetes prone BB rats. Diabetologia, 1990, 33, 573-575.
28. Morris, E. R., Rees, D. A. and Thorn, D., Characterization of alginate composition and block-structure by circular dichroism. Carbohydr. Res., 1980, 81, 305-314.
29. Edstrom, R. D., A colorimetric method for the determination of mucopolysaccharides and other acidic polymers. Analyt. Biochem., 1969, 29, 421-432.
30. Scudiero, D. A., Shoemaker, R. H., Paull, K. D. et al., Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res., 1988, 48, 4827-4833.
31. Gotfredsen, C. F., Steward, M. G., O'Shea, G. M., Vose, J. H., Horn, T. and Moody, A. J., The fate of transplanted encapsulated islets in spontaneously diabetic BB/WOR rats. Diabetes Res., 1990, 15, 157-163.
32. Cole, D. R., Waterfall, M., McIntyre, M. and Baird, J. D., Microencapsualted islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia, 1992, 35, 231-237.
33. Wijsman, J., Atkinson, P, Mazaheri, R. et al., Histological and immunopathological analysis of recovered encapsulated allogeneic islets from transplanted diabetic BB/W rats. Transplantation, 1992, 54, 588-592.
34. Mazaheri, R., Atkinson, P., Stiller, C., Dupre, J., Vose, J. and O'Shea, G., Transplantation of encapsulated allogeneic islets into diabetic BB/W rats. Effects of immunosuppression. Transplantation, 1991, 51, 750-754.
35. Fritschy, W. M., De Vos, P., Groen, H. et al., The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Transplant. Int., 1994, 7, 264-271.
36. Turner, T. D. T., Spyratou, O. and Schmidt, R. J., Biocompatibility of wound management products: standardization of and determination of cell growth rate in L929 fibroblast cultures. J. Pharm. Pharmacol., 1989, 41, 775-780.
37. De Vos, P., Wolters, G. H. J., Fritschy, W. M. and van Schilfgarde, R., Obstacles in the application of microencapsulation in islet transplantation. Int. J. Artif. Organs, 1993, 16, 205-212.